Option Care Health Q1 revenue rises 1.3%; adjusts 2026 net revenue guidance
Option Care Health reported first quarter 2026 net revenue of $1,350.7 million, up 1.3%, while adjusted EBITDA fell 6.3% to $104.8 million and adjusted diluted EPS was flat at $0.40. The company adjusted its full-year 2026 net revenue guidance to $5.675 billion to $5.775 billion and its cash flow target to at least $320 million, while keeping adjusted EBITDA and adjusted EPS guidance in place, which matters to shareholders because the revenue outlook has changed while profit measures are unchanged.
Key points
- Q1 2026 net revenue of $1,350.7 million, up 1.3%; GAAP net income of $45.3 million, down 3.0%
- Adjusted EBITDA of $104.8 million, down 6.3%; adjusted diluted EPS of $0.40, flat year over year
- Full-year 2026 guidance: net revenue $5.675 billion to $5.775 billion; adjusted diluted EPS $1.82 to $1.92; adjusted EBITDA $480 million to $505 million
- Cash used in operating activities was $12.1 million in Q1; Company repurchased $17.5 million of stock and expanded its revolving credit facility from $400 million to $850 million
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:00 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 30, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.